The LDL-cholesterol to CHD ratio is the same as the Base case
at 1 to 2.2, while the ratio of CHD incidence to costs is also at 1 to 0.8. These estimates
result in annual societal cost savings from reduced incidences of CHD of $41.98 million,
as shown in Table 4.